Navigation Links
PRA International Experts to Chair BioPharma Asia Panels
Date:3/29/2011

RALEIGH, N.C., March 29, 2011 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces that two of our operational experts will conduct country-focused roundtable sessions at the 4th Annual BioPharma Asia Convention being held in Singapore 28-31 March 2011. PRA will also host an exhibit at booth A01.

Day two of the convention will feature interactive roundtables exploring drug development concerns in six key Asian countries. PRA's Dr. Yooni Kim, Senior Manager of Clinical Operations, will lead the South Korea roundtable, while Dr. Pramod Kabra, Director of Clinical Operations, will conduct the India session. Attendees will have the opportunity to exchange ideas with the hosts and gain further insight into country-specific innovations, policies and strategies.

Dr. Kim, based in PRA's Seoul office, has over 10 years of clinical research experience with major pharmaceutical companies and as a researcher at the Seoul National University Hospital Clinical Trial Center. She also serves on the advisory task force at KFDA, South Korea's regulatory authority.

Working from PRA's office in Mumbai, Dr. Kabra has nearly 15 years of experience in the pharmaceutical and CRO industries, including clinical practice, bioequivalence and Phase I - IV studies. He has coordinated and monitored approximately 100 clinical studies across various therapeutic areas. 

Additional PRA representatives from our Clinical Operations and Business Development groups will be available to discuss our capabilities in Asia and successful approach to drug development. Since 2008, PRA has participated in more than 115 studies in the region, and we have been strategically expanding our presence there for more than a decade. PRA has offices in South Korea, India, Taiwan, China and Hong Kong.

About PRA

PRA conducts clinical trials across all therapeutic areas in more than 80 countries and provides services in all phases of clinical development through its 39 global offices.

PRA's therapeutic expertise, global reach and project experience combined with its extensive local knowledge and differentiating philosophy—THE PERSONAL ELEMENT— enable its project teams to deliver consistent and on-time performance. This unique PRA philosophy recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to be innovative and to use their personal commitment to accelerate the development life cycle.

To learn more about PRA International, please visit www.PRAinternational.com, email Endpoints@PRAintl.com or call our Global Headquarters at +1 (919) 786-8200.


'/>"/>
SOURCE PRA International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HeartWare International Receives Approval From the Therapeutic Goods Administration (TGA) in Australia
2. PRA International Experts to Speak at Industry Events
3. Cellular Dynamics International and Roche Transition Early Access Collaboration into a Standard Supply Agreement Ahead of Schedule
4. DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2010
5. International Medical Corps Team in Hardest-Hit Coastal Communities Finds Severe Shortages of Food, Water, Medicines; Acute Need for Mental Health Support
6. Pharmaceutics International Inc. (Pii) Announces Appointment of Rampurna Prasad Gullapalli, Ph.D. as Vice President of Drug Delivery Technologies
7. Bacterin International Holdings, Inc. Schedules Conference Call to Present Fourth Quarter and Full Year 2010 Financial Results
8. International Biotech Firm Funds Research Into Aging Through Foundation of UMDNJ
9. Chindex International, Inc. Reports Financial Results for the Three and Nine Month Period Ended December 31, 2010
10. Survey Sampling International Names Chris DeAngelis to Head New SSI Health
11. Cynosure Receives International Marketing Clearances for New Cellulite, Laser Lipolysis Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... Dec. 6, 2016  Nearly 30 million people in ... the epidemic of diabetes. 1 However, nearly 40% ... glucose levels (hyperglycemia) and significant glucose variability. 2 These ... including cardiovascular events. If left untreated, hyperglycemia can lead ... disease or blindness. 3 As part ...
(Date:12/6/2016)... , Dec. 6, 2016 With opioids commonly used for ... the prescription drug market that has led to nationwide fatalities. ... to eight times stronger than heroin or morphine, resulting in likelihood ... , ... , vice president, clinical operations, Behavioral Health for HMC HealthWorks, explained ...
(Date:12/6/2016)...  Blueprint Medicines Corporation (NASDAQ: BPMC ), ... for patients with genomically defined diseases, today announced that ... million in shares of its common stock. In addition, ... option to purchase up to an additional of $18,750,000 ... with the public offering. All shares of common stock ...
Breaking Medicine Technology:
(Date:12/6/2016)... BROOK, Ill. (PRWEB) , ... December 06, 2016 ... ... disruptions in their brain networks that can be seen on a type of ... disease (PD) is a progressive disorder of the central nervous system characterized by ...
(Date:12/6/2016)... ... December 06, 2016 , ... Men with gum disease are ... serious health problems, such as cardiovascular illness, according to research cited in a ... Periodontics & Dental Implant Center notes that the correlation between periodontal disease and ...
(Date:12/6/2016)... ... ... According to a November 1 article published on Bustle, there ... drinking enough water, which can cause bad breath (known medically as halitosis). Dr. Farzad ... not only helps reduce the possibility of bad breath, but it can provide individuals ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... named Ajdin Camaga as a vice president of sales. , “Ajdin understands that ... “He works hard to understand what each client needs, and is persistent in ...
(Date:12/6/2016)... ... December 06, 2016 , ... Mount Sinai Health System today ... of Neurosurgery, where clinicians can confer and order 3D models for their cases. ... basis with quick turnaround times. This resource will be the first of its ...
Breaking Medicine News(10 mins):